Nuvectis Pharma
At close: Sep 30
After Hours: 8:44AM EDT
Day Range7.09 - 7.4752 Wk Range3.08 - 20.92Open / Close7.4 / 7.09Float / Outstanding8.2M / 14.6M
Vol / Avg.10.8K / 16KMkt Cap103.8MP/E-50d Avg. Price8.63
Div / Yield-Payout Ratio-Total Float8.2MEPS-0.28

Nuvectis Pharma Stock (NASDAQ:NVCT), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1


Highest Price Target1


Lowest Price Target1


Consensus Price Target1


Analyst Rating Summary1


Analyst Firms Making Recommendations1

  • Ladenburg Thalmann
  • HC Wainwright & Co.

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for Nuvectis Pharma

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

Nuvectis Pharma Questions & Answers

What is the target price for Nuvectis Pharma (NVCT)?

The latest price target for Nuvectis Pharma (NASDAQ: NVCT) was reported by Ladenburg Thalmann on July 13, 2022. The analyst firm set a price target for $21.00 expecting NVCT to rise to within 12 months (a possible 196.19% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Nuvectis Pharma (NVCT)?

The latest analyst rating for Nuvectis Pharma (NASDAQ: NVCT) was provided by Ladenburg Thalmann, and Nuvectis Pharma initiated their buy rating.

When is the next analyst rating going to be posted or updated for Nuvectis Pharma (NVCT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuvectis Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuvectis Pharma was filed on July 13, 2022 so you should expect the next rating to be made available sometime around July 13, 2023.

Is the Analyst Rating Nuvectis Pharma (NVCT) correct?

While ratings are subjective and will change, the latest Nuvectis Pharma (NVCT) rating was a initiated with a price target of $0.00 to $21.00. The current price Nuvectis Pharma (NVCT) is trading at is $7.09, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.